loadpatents
name:-0.015594005584717
name:-0.0097789764404297
name:-0.16744995117188
Pachur; Thorsten Patent Filings

Pachur; Thorsten

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pachur; Thorsten.The latest application filed is for "process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines".

Company Profile
0.13.17
  • Pachur; Thorsten - Biberach an der Riss DE
  • Pachur; Thorsten - Schwendi N/A DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines
Grant 9,751,855 - Pfrengle , et al. September 5, 2
2017-09-05
Process For The Preparation Of Chiral 8-(3-aminopiperidin-1-yl)-xanthines
App 20170129872 - PFRENGLE; Waldemar ;   et al.
2017-05-11
Process For The Preparation Of Chiral 8-(3-aminopiperidin-1-yl)-xanthines
App 20170029402 - PFRENGLE; Waldemar ;   et al.
2017-02-02
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines
Grant 9,499,546 - Pfrengle , et al. November 22, 2
2016-11-22
Co-crystals and salts of CCR3-inhibitors
Grant 9,233,950 - Frank , et al. January 12, 2
2016-01-12
Process and intermediates for preparing GPR40 agonists
Grant 9,051,289 - Dahmann , et al. June 9, 2
2015-06-09
Co-crystals And Salts Of Ccr3-inhibitors
App 20150105371 - FRANK; Markus ;   et al.
2015-04-16
Process And Intermediates For Preparing Gpr40 Agonists
App 20150087829 - DAHMANN; Georg ;   et al.
2015-03-26
Process For The Preparation Of Chiral 8-(3-aminopiperidin-1-yl)-xanthines
App 20150025089 - PFRENGLE; Waldemar ;   et al.
2015-01-22
Process for the preparation of chiral 8-(3-aminopiperidin-1-yl)-xanthines
Grant 8,883,805 - Pfrengle , et al. November 11, 2
2014-11-11
Co-crystals and salts of CCR3-inhibitors
Grant 8,742,115 - Frank , et al. June 3, 2
2014-06-03
Co-crystals And Salts Of Ccr3-inhibitors
App 20140135307 - FRANK; Markus ;   et al.
2014-05-15
Acid Addition Salts Of The 2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]-(methyl)amino]ethoxy]-n-me- Thyl-n-[3-(4-methylpiperazin-1-yl)cyclohexyl] Acetamide And The Use Thereof As Bradykinin B1 Receptorantagonists
App 20130289049 - Pachur; Thorsten ;   et al.
2013-10-31
Process for the preparation of chiral 8-(3-aminopiperidin-1yl)-xanthines
Grant 8,541,450 - Pfrengle , et al. September 24, 2
2013-09-24
Process For The Preparation Of Chiral 8-(3-aminopiperidin-1-yl)-xanthines
App 20130178485 - PFRENGLE; Waldemar ;   et al.
2013-07-11
Co-crystals And Salts Of Ccr3-inhibitors
App 20120264729 - Frank; Markus ;   et al.
2012-10-18
Process For Preparing Cycloalkyl-substituted Piperazine Compounds
App 20110301350 - Pfrengle; Waldemar ;   et al.
2011-12-08
Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines
Grant 7,820,815 - Pfrengle , et al. October 26, 2
2010-10-26
Process For The Preparation Of Chiral 8-(3-aminopiperidin-1yl)-xanthines
App 20090192314 - PFRENGLE; Waldemar ;   et al.
2009-07-30
Process for the preparation of chiral 8-(-3-aminopiperidin-1-yl) xanthines
App 20060142310 - Pfrengle; Waldemar ;   et al.
2006-06-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed